Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CODA Biotherapeutics launches with $19mm Series A round

Executive Summary

Neurological disease-focused CODA Biotherapeutics Inc. (chemogenetic gene therapy platform) launched with a $19mm Series A round co-led by MPM Capital and Versant Ventures, which were joined by Astellas Venture Management and Novartis.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies